ObamaCare is a national experiment, testing whether this nation’s government can expand coverage and control costs. Whether the experiment succeeds or fails rests in the hands of the American people, who will vote in November 2014 to retain or turn out the political leadership of Congress.
Thursday, March 27, 2014
The ObamaCare – The Great Social and Economic
Experiment
A great
social and economic experiment, noble in
motive and far-reaching in purpose.
President
Herbert Hoover(1874-1964), referring to Prohibition, 1931
The preservation
of the sacred fire of liberty, and the destiny of the republican model of
government, are justly considered as deeply, perhaps as finally staked, on the
experiment entrusted to the hands of the American people.
President
George Washington (1732-1799), First
Inaugural Address, 1789
When I think of ObamaCare, I think of Prohibition. Both were
and are vast social and economic experiments. Both were and are noble in purpose and far-reaching in purpose. Both, as with most experiments, are destined
to either succeed or fail. And both, after a long run of experimentation, will either endure or fall by the
wayside. Prohibition lasted 14
years. How long ObamaCare will last is
indeterminate.
ObamaCare is a national experiment, testing whether this nation’s government can expand coverage and control costs. Whether the experiment succeeds or fails rests in the hands of the American people, who will vote in November 2014 to retain or turn out the political leadership of Congress.
According to a 39 page report “The Patient Protection and
Affordability Act: From Theory to Boots on the Ground – Part I,” which you may
access at PhysiciansFoundation.org, the critical issues facing the electorate are:
One, Rate Shock, whether
the premium offerings offered under the various ObamaCare plans are too high or are affordable. These offerings are closely tied to how
insurers respond, how many plans they offer, and their rates for different groups. How insurers respond, in turn, will be affected
by how enrollees of different ages, incomes, and subsidy levels respond.
The response so far has been tenuous and mixed. The young and uninsured appear to have a
jaundiced view of the new plans and have been reluctant to enroll and pay their
first premium. On the other hand, older citizens, 35 to 64, are signing on in significant numbers.
Two, Adverse Selection,
whether the initial open enrollment period,
supposedly ending on March 31, 2014, attracts enough of the young and
healthy to offset the costs of older and less healthy enrollees. The mix will profoundly affect average plan
costs, plan margins, and future premiums.
According to the authors of the Physician Foundation Report, Kathy Means,
a national expert on Medicare, Medicaid, and health care reform, and Ken
Monroe, CEO of Bostrom, a nonprofit
professional and management firm, “This
first year is in many ways a truly experimental year. A more crucial test could be what happens to
insurer participation, plan offerings and relative premium levels in Year 2
based on Year 1 results.”
Year 1 will end in January 2015, and Year 2 will commence on
that date. In my opinion, the outcome
of the November 2014 elections will determine whether ObamaCare carries on or
whether it collapses or is eventually changed beyond recognition or
repealed. These events will be shaped by
how ObamaCare’s “social engineering” affects the Medicare program and how senior
voters respond to ObamaCare changes.
Tweet: ObamaCare is a vast social and economic
experiment, and its future will be determined by the 2014 midterm elections and
by rate shock in 2014 and adverse selection in 2014 and 2015.
Source: Kathy Means and Ken
Monroe, “The Patient Protection and
Affordability Act: From Theory to Boots on the Ground – Part I,” commissioned by
the Physicians Foundation. To access
and read, go to physiciansfoundation.org.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment